Unrelated cord blood transplantation after reduced intensity conditioning (RIC) in adults with hematological malignancy. An EBMT-Eurocord-Netcord, Societe Francaise de Greffe de Moelle et de Therapie Cellulaire and University of Minnesota Collaborative Study

被引:0
|
作者
Rocha, Vanderson [1 ]
Rio, Bernard [2 ]
Brunstein, Claudio [3 ]
Renaud, Marc [2 ]
Olivieri, Attilio [1 ]
Sirvent, Anne [2 ]
Tabrizi, Reza [2 ]
Uzunov, Madalina [2 ]
Boudjedir, Karim [1 ]
Ionescu, Irina [1 ]
Rodrigues, Celso A. [1 ]
Gluckman, Eliane [1 ]
Blaise, Didier [2 ]
Wagner, John E. [3 ]
机构
[1] Hop St Louis, Eurocord Off, Paris, France
[2] Societe Francoise Greffe Moelle Therapie Cell, Marseille, France
[3] Univ Minnesota, Blood & Marrow Transplant Program, Minneapolis, MN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2027
引用
收藏
页码:603A / 604A
页数:2
相关论文
共 50 条
  • [31] REDUCED-INTENSITY CONDITIONING (RIC) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FOR PATIENTS AGED ≥60 YEARS: A RETROSPECTIVE ANALYSIS OF 629 PATIENTS FROM THE SOCIETE FRANCAISE DE GREFFE DE MOELLE ET DE THERAPIE CELLULAIRE (SFGM-TC)
    Mohty, M.
    Blaise, D.
    Milpied, N.
    Michallet, M.
    Vernant, J. P.
    Fegueux, N.
    Guilhot, F.
    Rio, B.
    Gratecos, N.
    Cahn, J. Y.
    Socie, G.
    Yakoub-Agha, I
    Huynh, A.
    Francois, S.
    Bay, J. O.
    Cordonnier, C.
    Buzyn, A.
    Contentin, N.
    Deconinck, E.
    Chevallier, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S162 - S162
  • [32] Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen (RICT): Impact of pretransplant and posttransplant factors on outcome. A study from La Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC).
    Michallet, MM
    Le, QHQH
    Chir, ZZ
    Bilger, KK
    Attal, MM
    Huyn, AA
    Blaise, DD
    Milpied, NN
    Moreau, PR
    Bordigoni, PP
    Kuentz, MM
    Sadoun, AA
    Cahn, JYJY
    Socie, GG
    Furst, SS
    Thomas, XX
    Michallet, ASAS
    Jouet, JPJP
    Boiron, JMJM
    BLOOD, 2003, 102 (11) : 197A - 198A
  • [33] Interactions Between Total Nucleated and CD34 Cell Dose and Their Impact on Outcomes After Single and Double Unrelated Cord Blood Transplantation for Patients with Hematological Malignancies. An Analysis on Behalf of Societe' Francaise De Greffe De Moelle Et Therapie Cellulaire (SFGM-TC) and Eurocord
    Michallet, Mauricette
    Cunha, Renato L. G.
    Michel, Gerard
    Socie, Gerard
    Mohty, Mohamad
    Rio, Bernard
    Blaise, Didier
    Sirvent, Anne
    Tabrizzi, Reza
    Bordigoni, Pierre
    Deconinck, Eric
    Yakoubagha, Ibrahim
    Rossi, Jean-Francois
    Maillard, Natacha
    Sobh, Mohamad
    Garnier, Federico
    Ruggeri, Annalisa
    Gluckman, Eliane
    Rocha, Vanderson
    BLOOD, 2010, 116 (21) : 163 - 164
  • [34] Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
    Weil, D. Roos
    Moreau, P.
    Avet-Loiseau, H.
    Kuentz, M.
    Milpied, N.
    Socie, G.
    Furst, S.
    Huynh, A.
    Vigouroux, S.
    Le Gouill, S.
    Thiebault, A.
    Buzyn, A.
    Cahn, J. -Y.
    Maillard, N.
    Yakoub-Agha, I.
    Soulier, J.
    Raus, N.
    Fermand, J. -P.
    Rio, B.
    Golmard, J. L.
    Attal, M.
    Blaise, D.
    Michallet, M.
    Dhedin, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S18 - S18
  • [35] Updated analysis of haematopoietic stem cell transplantations after reduced-intensity conditioning regimen for haematological malignancies from the Societe Francaise de Greffe de Moelle Osseuse et de Therapie Cellulaire (SFGM-TC) Registry
    Michallet, M
    Le, QH
    Prebet, T
    Boiron, J
    Yakoub-Agha, I
    Esperou, H
    Deconninck, E
    Blaise, D
    BONE MARROW TRANSPLANTATION, 2006, 37 : S193 - S193
  • [36] Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
    Chantepie, S. P.
    Mohty, M.
    Tabrizi, R.
    Robin, M.
    Deconinck, E.
    Buzyn, A.
    Contentin, N.
    Raus, N.
    Lheritier, V.
    Reman, O.
    BONE MARROW TRANSPLANTATION, 2013, 48 (05) : 684 - 690
  • [37] Allogeneic haematopoietic stem cell transplantation after reduced-intensity conditioning regimen from Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC):: study of pre-transplant and post-transplant factors on outcome
    Michallet, M
    Le, Q
    Chir, Z
    Bilger, K
    Attal, M
    Huyn, A
    Blaise, D
    Milpied, N
    Moreau, P
    Bordigoni, P
    Kuentz, M
    Sadoun, A
    Cahn, JY
    Socie, G
    Fürst, S
    Thomas, X
    Michallet, AS
    Jouet, JP
    Boiron, JM
    BONE MARROW TRANSPLANTATION, 2004, 33 : S12 - S12
  • [38] Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Societe rancaise de Greffe de Moelle Osseuse et Therapie Cellulaire and Eurocord
    Nguyen, S.
    Achour, A.
    Souchet, L.
    Vigouroux, S.
    Chevallier, P.
    Furst, S.
    Sirvent, A.
    Bay, J-O
    Socie, G.
    Ceballos, P.
    Huynh, A.
    Cornillon, J.
    Francois, S.
    Legrand, F.
    Yakoub-Agha, I.
    Michel, G.
    Maillard, N.
    Margueritte, G.
    Maury, S.
    Uzunov, M.
    Bulabois, C-E
    Michallet, M.
    Clement, L.
    Dauriac, C.
    Bilger, K.
    Lejeune, J.
    Beziat, V.
    Rocha, V.
    Rio, B.
    Chevret, S.
    Vieillard, V.
    BONE MARROW TRANSPLANTATION, 2017, 52 (10) : 1428 - 1435
  • [39] A survey of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire for non-medical recommendations given to patients going home after allogeneic haematopoietic stem cell transplantation
    Samy, J. -P.
    Cordonnier, C.
    Chassang, A.
    Chatellard, B.
    Soulie, B.
    Corroyer, F.
    Renk, M.
    Wallart, A.
    Vildary, C.
    Remy, C.
    Michallet, M.
    Guillerm, G.
    Mialou, V.
    Letort-Bertrand, M.
    Gire, M.
    Aude, M. -C.
    Bernard, M.
    Lacroix, H.
    Porcheron, S.
    Bordigoni, P.
    Milpied, N.
    Yakoub-Agha, I.
    Robin, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S358 - S358
  • [40] The use of bone marrow graft for haematopoietic stem cell transplantation from matched unrelated donors after reduced-intensity conditioning regimen improves survival: analysis of the Societe Francaise de Greffe de Moe Ile et de Therapie Cellulaire
    Toma, A.
    Balere, M. L.
    Boiron, J. -M.
    Bordigoni, P.
    Socie, G.
    Vernant, J.
    Renaud, M.
    Milpied, N.
    Michalet, M.
    Deconinck, E.
    Guyotat, D.
    Garban, F.
    Sirvent, A.
    Contentin, N.
    Blaise, D.
    Marry, E.
    Buzyn, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S286 - S286